Overall Technical outlook

Price Summary

On 2025-09-05, Gland Pharma Limited's shares started at 1885.0, peaked at 1940.0, bottomed out at 1880.1, and ended 0.38% higher at 1892.2, with 160215 shares traded.
The stock's highest price over the 52-week span is 2102.1, while the lowest price is 1392.8.
12 analysts suggest that GLAND's future price will lie between 1138.0 and 2340.0, with an average expected price of roughly 1865.6666.

Technicals

Support and Resistance: The current price for GLAND is 1892.2, supported at 1888.3 with resistance at 2000.3. This indicates a trading range where 1888.3 might prevent further declines, while 2000.3 could hinder additional gains.
GLAND supportResistance 243efc
Support/Resistance for GLAND


Aroon: The AROON is showing a neutral stance, not indicating a clear upward or downward trend for Gland Pharma Limited. This suggests a period of market balance, where neither side is showing dominance.
GLAND aroon 243efc
Aroon chart for Gland Pharma Limited


Bol. Bands: The BOLL BANDS is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
GLAND bbands 243efc
Bolinger Bands chart for Gland Pharma Limited


Parabolic SAR: The PSAR remains bearish, establishing a resistance level that could cap any potential upward trends. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult to achieve significant gains for GLAND.
GLAND psar 243efc
Parabolic Stop and Reverse chart for Gland Pharma Limited


Stochastic: The STOCHASTIC is showing a neutral stance, with no definitive indication of an upward or downward trend for GLAND. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
GLAND stoch 243efc
Stochastic chart for Gland Pharma Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
GLAND trippleSMA 243efc
Tripple SMA chart for Gland Pharma Limited


The technical analysis of a company's stock performance is valuable, but only when considered in conjunction with the company's fundamentals. These fundamentals, including financial strength, earnings growth, and leadership, provide a foundation for understanding market movements. Additionally, industry trends and competitive pressures play an important role. By integrating both fundamental and technical analysis, one can better evaluate the company's true potential and make more informed investment decisions.